Skip to Content

Nurofen Plus – MIMS – Serious clinical harms with higher than recommended doses

01/12/2022
Medicines for human use Safety update

This article was produced by the HPRA for publication in the December edition of Monthly Index of Medical Specialties (MIMS) and describes serious clinical harms, including, renal tubular acidosis and severe hypokalaemia following prolonged use of codeine/ibuprofen at higher than recommended doses.

Documents

Opens in new window Neurofen Plus - MIMS - Dec 2022 PDF : 74KB | 02/07/2024